Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod IncfiledCriticalPfizer Prod Inc
Publication of TNSN01081A1publicationCriticalpatent/TNSN01081A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
L'INVENTION CONCERNE DES COMPOSITIONS PHARMACEUTIQUES CONTENANT DE LA S-METHYL-DIHYDRO-ZIPRASIDONE. ELLE CONCERNE EGALEMENT DES COMPOSITIONS PHARMACEUTIQUES CONTENANT DES SELS PHARMACEUTIQUEMENT ACCEPTABLES DUDIT COMPOSE. APPLICATION : UTILISATION DE CES COMPOSITIONS POUR LE TRAITEMENT DE TROUBLES PSYCHIATRIQUES ET DE TROUBLES OCULAIRES.THE INVENTION RELATES TO PHARMACEUTICAL COMPOSITIONS CONTAINING S-METHYL-DIHYDRO-ZIPRASIDONE. IT ALSO CONCERNS PHARMACEUTICAL COMPOSITIONS CONTAINING PHARMACEUTICALLY ACCEPTABLE SALTS OF SAID COMPOUND. APPLICATION: USE OF THESE COMPOSITIONS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS AND EYE DISORDERS.